TLR4 activates NF-κB in human ovarian granulosa tumor cells

Biochemical and Biophysical Research Communications

Volumn 409, Issue 4, 2011, Pages 675-680

  Woods, Dori C ^a   White, Yvonne A R ^a   Dau, Caroline ^c   Johnson, A L ^b  

^a MASSACHUSETTS GENERAL HOSPITAL   (United States)

^b PENNSYLVANIA STATE UNIVERSITY   (United States)

^c UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Granulosa cell tumor; Lipopolysaccharide; LPS; Ovarian cancer; Ovary; TLR; Toll like receptor

Indexed keywords

BACTERIUM LIPOPOLYSACCHARIDE; CISPLATIN; HEAT SHOCK PROTEIN 60; IMMUNOGLOBULIN ENHANCER BINDING PROTEIN; MYELOID DIFFERENTIATION FACTOR 88; RECOMBINANT TUMOR NECROSIS FACTOR RELATED APOPTOSIS INDUCING LIGAND; TOLL LIKE RECEPTOR 2; TOLL LIKE RECEPTOR 4; TUMOR NECROSIS FACTOR ALPHA;

ARTICLE; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GRANULOSA CELL TUMOR; HUMAN; HUMAN CELL; MICROBIAL ATTENUATION; NUCLEAR LOCALIZATION SIGNAL; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; REAL TIME POLYMERASE CHAIN REACTION; TREATMENT OUTCOME; TUMOR CELL LINE; WESTERN BLOTTING;

CELL LINE, TUMOR; CISPLATIN; DRUG RESISTANCE, NEOPLASM; FEMALE; GRANULOSA CELL TUMOR; HUMANS; NF-KAPPA B; OVARIAN NEOPLASMS; TNF-RELATED APOPTOSIS-INDUCING LIGAND; TOLL-LIKE RECEPTOR 4;

BACTERIA (MICROORGANISMS);

EID: 79959211160     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2011.05.063     Document Type: Article

References (28)

1. Schumer S.T., Cannistra S.A. Granulosa cell tumor of the ovary. J. Clin. Oncol. 2003, 21:1180-1189.
2. Colombo N., Parma G., Zanagnolo V., Insinga A. Management of ovarian stromal cell tumors. J. Clin. Oncol. 2007, 25:2944-2951.
3. Nishi Y., Yanase T., Mu Y., Oba K., Ichino I., Saito M., Nomura M., Mukasa C., Okabe T., Goto K., Takayanagi R., Kashimura Y., Haji M., Nawata H. Establishment and characterization of a steroidogenic human granulosa-like tumor cell line, KGN, that expresses functional follicle-stimulating hormone receptor. Endocrinology 2001, 142:437-445.
4. Zhang H., Vollmer M., De Geyter M., Litzistorf Y., Ladewig A., Durrenberger M., Guggenheim R., Miny P., Holzgreve W., De Geyter C. Characterization of an immortalized human granulosa cell line (COV434). Mol. Hum. Reprod. 2000, 6:146-153.
5. Shimada M., Hernandez-Gonzalez I., Gonzalez-Robanya I., Richards J.S. Induced expression of pattern recognition receptors in cumulus oocyte complexes: novel evidence for innate immune-like functions during ovulation. Mol. Endocrinol. 2006, 20:3228-3239.
6. Kelly M.G., Alvero A.B., Chen R., Silasi D.A., Abrahams V.M., Chan S., Visintin I., Rutherford T., Mor G. TLR-4 signaling promotes tumor growth and paclitaxel chemoresistance in ovarian cancer. Cancer Res. 2006, 66:3859-3868.
7. Molteni M., Marabella D., Orlandi C., Rossetti C. Melanoma cell lines are responsive in vitro to lipopolysaccharide and express TLR-4. Cancer Lett. 2006, 235:75-83.
8. Zhou M., McFarland-Mancini M.M., Funk H.M., Husseinzadeh N., Mounajjed T., Drew A.F. Toll-like receptor expression in normal ovary and ovarian tumors. Cancer Immunol. Immunother. 2009, 58:1375-1385.
9. Richards J.S., Russell D.L., Ochsner S., Espey L.L. Ovulation: new dimensions and new regulators of the inflammatory-like response. Annu. Rev. Physiol. 2002, 64:69-92.
10. Woods D.C., Schorey J.S., Johnson A.L. Toll-like receptor signaling in hen ovarian granulosa cells is dependent on stage of follicle maturation. Reproduction 2009, 137:987-996.
11. Szajnik M., Szczepanski M.J., Czystowska M., Elishaev E., Mandapathil M., Nowak-Markwitz E., Spaczynski M., Whiteside T.L. TLR4 signaling induced by lipopolysaccharide or paclitaxel regulates tumor survival and chemoresistance in ovarian cancer. Oncogene 2009, 28:4353-4363.
12. Halaas O., Vik R., Ashkenazi A., Espevik T. Lipopolysaccharide induces expression of APO2 ligand/TRAIL in human monocytes and macrophages. Scand. J. Immunol. 2000, 51:244-250.
13. Huang B., Zhao J., Unkeless J.C., Feng Z.H., Xiong H. TLR signaling by tumor and immune cells: a double-edged sword. Oncogene 2008, 27:218-224.
14. Yang G., Xiao X., Rosen D.G., Cheng X., Wu X., Chang B., Liu G., Xue F., Mercado-Uribe I., Chiao P., Du X., Liu J. The biphasic role of NF-{kappa}B in progression and chemoresistance of ovarian cancer. Clin. Cancer Res. 2011, 17:2181-2194.
15. Woods D.C., Liu H.K., Nishi Y., Yanase T., Johnson A.L. Inhibition of proteasome activity sensitizes human granulosa tumor cells to TRAIL-induced cell death. Cancer Lett. 2008, 260:20-27.
16. Woods D.C., Johnson A.L. Protein kinase C activity mediates LH-induced ErbB/Erk signaling in differentiated hen granulosa cells. Reproduction 2007, 133:733-741.
17. Livak K.J., Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) Method. Methods 2001, 25:402-408.
18. Brown K., Gerstberger S., Carlson L., Franzoso G., Siebenlist U. Control of I kappa B-alpha proteolysis by site-specific, signal-induced phosphorylation. Science 1995, 267:1485-1488.
19. Boehm J.S., Zhao J.J., Yao J., Kim S.Y., Firestein R., Dunn I.F., Sjostrom S.K., Garraway L.A., Weremowicz S., Richardson A.L., Greulich H., Stewart C.J., Mulvey L.A., Shen R.R., Ambrogio L., Hirozane-Kishikawa T., Hill D.E., Vidal M., Meyerson M., Grenier J.K., Hinkle G., Root D.E., Roberts T.M., Lander E.S., Polyak K., Hahn W.C. Integrative genomic approaches identify IKBKE as a breast cancer oncogene. Cell 2007, 129:1065-1079.
20. Woods D.C., Alvarez C., Johnson A.L. Cisplatin-mediated sensitivity to TRAIL-induced cell death in human granulosa tumor cells. Gynecol. Oncol. 2008, 108:632-640.
21. Dunzendorfer S., Lee H.K., Soldau K., Tobias P.S. Toll-like receptor 4 functions intracellularly in human coronary artery endothelial cells: roles of LBP and sCD14 in mediating LPS responses. FASEB J. 2004, 18:1117-1119.
22. Jeremias I., Kupatt C., Baumann B., Herr I., Wirth T., Debatin K.M. Inhibition of nuclear factor kappaB activation attenuates apoptosis resistance in lymphoid cells. Blood 1998, 91:4624-4631.
23. Keane M.M., Rubinstein Y., Cuello M., Ettenberg S.A., Banerjee P., Nau M.M., Lipkowitz S. Inhibition of NF-kappaB activity enhances TRAIL mediated apoptosis in breast cancer cell lines. Breast Cancer Res. Treat. 2000, 64:211-219.
24. Sheridan J.P., Marsters S.A., Pitti R.M., Gurney A., Skubatch M., Baldwin D., Ramakrishnan L., Gray C.L., Baker K., Wood W.I., Goddard A.D., Godowski P., Ashkenazi A. Control of TRAIL-induced apoptosis by a family of signaling and decoy receptors. Science 1997, 277:818-821.
25. Jang Y.J., Park K.S., Chung H.Y., Kim H.I. Analysis of the phenotypes of Jurkat clones with different TRAIL-sensitivities. Cancer Lett. 2003, 194:107-117.
26. Pawlowski J.E., Nesterov A., Scheinman R.I., Johnson T.R., Kraft A.S. NF-kappa B does not modulate sensitivity of renal carcinoma cells to TNF alpha-related apoptosis-inducing ligand (TRAIL). Anticancer Res. 2000, 20:4243-4255.
27. Yamanaka T., Shiraki K., Sugimoto K., Ito T., Fujikawa K., Ito M., Takase K., Moriyama M., Nakano T., Suzuki A. Chemotherapeutic agents augment TRAIL-induced apoptosis in human hepatocellular carcinoma cell lines. Hepatology 2000, 32:482-490.
28. Luo J.L., Maeda S., Hsu L.C., Yagita H., Karin M. Inhibition of NF-kappaB in cancer cells converts inflammation- induced tumor growth mediated by TNFalpha to TRAIL-mediated tumor regression. Cancer Cell 2004, 6:297-305.